You just read:

Phase 1 Data on MM-121 Will Be Presented at the 102nd Annual Meeting of the American Association for Cancer Research (AACR)

News provided by

Merrimack Pharmaceuticals, Inc.

Apr 05, 2011, 11:08 ET